POLY(BUTYL ACRYLATE-CO-BUTYL METHACRYLATE-CO-METHACRYLIC ACID-CO-METHYL METHACRYLATE-CO-STYRENE)
General Information
Mainterm | POLY(BUTYL ACRYLATE-CO-BUTYL METHACRYLATE-CO-METHACRYLIC ACID-CO-METHYL METHACRYLATE-CO-STYRENE) |
CAS Reg.No.(or other ID) | 25950-40-7 |
Regnum |
175.105 176.170 176.180 177.1010 178.3790 |
From www.fda.gov
Computed Descriptors
Download SDF2D Structure | |
CID | 168443 |
IUPAC Name | butyl 2-methylprop-2-enoate;butyl prop-2-enoate;ethylbenzene;methyl 2-methylprop-2-enoate;2-methylprop-2-enoic acid |
InChI | InChI=1S/C8H14O2.C8H10.C7H12O2.C5H8O2.C4H6O2/c1-4-5-6-10-8(9)7(2)3;1-2-8-6-4-3-5-7-8;1-3-5-6-9-7(8)4-2;1-4(2)5(6)7-3;1-3(2)4(5)6/h2,4-6H2,1,3H3;3-7H,2H2,1H3;4H,2-3,5-6H2,1H3;1H2,2-3H3;1H2,2H3,(H,5,6) |
InChI Key | ICKYHPGOQSKLHK-UHFFFAOYSA-N |
Canonical SMILES | CCCCOC(=O)C=C.CCCCOC(=O)C(=C)C.CCC1=CC=CC=C1.CC(=C)C(=O)O.CC(=C)C(=O)OC |
Molecular Formula | C32H50O8 |
From Pubchem
Computed Properties
Property Name | Property Value |
---|---|
Molecular Weight | 562.744 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 14 |
Complexity | 453.0 |
CACTVS Substructure Key Fingerprint | A A A D c f B 8 P A A A A A A A A A A A A A A A A A A A A A A A A A A w A A A A A A A A A A A B A A A A G g A A C A A A D A C g m A I y C I A A B g C I A i D S C A A C A A A g A A A I i A E A A M g I J C K A M R C C Y A A k g A A I u I c A g I A O A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A = = |
Topological Polar Surface Area | 116.0 |
Monoisotopic Mass | 562.351 |
Exact Mass | 562.351 |
Compound Is Canonicalized | True |
Formal Charge | 0 |
Heavy Atom Count | 40 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Isotope Atom Count | 0 |
Covalently-Bonded Unit Count | 5 |
From Pubchem
ADMET Predicted Profile --- Classification
Model | Result | Probability |
---|---|---|
Absorption | ||
Blood-Brain Barrier | BBB+ | 0.7361 |
Human Intestinal Absorption | HIA+ | 0.7616 |
Caco-2 Permeability | Caco2+ | 0.6514 |
P-glycoprotein Substrate | Substrate | 0.5924 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.6270 |
Non-inhibitor | 0.7541 | |
Renal Organic Cation Transporter | Non-inhibitor | 0.8180 |
Distribution | ||
Subcellular localization | Mitochondria | 0.7239 |
Metabolism | ||
CYP450 2C9 Substrate | Non-substrate | 0.8782 |
CYP450 2D6 Substrate | Non-substrate | 0.8788 |
CYP450 3A4 Substrate | Substrate | 0.5311 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.7843 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.8204 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.8770 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.7125 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.5936 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8472 |
Excretion | ||
Toxicity | ||
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9016 |
Non-inhibitor | 0.8823 | |
AMES Toxicity | Non AMES toxic | 0.8165 |
Carcinogens | Non-carcinogens | 0.7516 |
Fish Toxicity | High FHMT | 0.9744 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9994 |
Honey Bee Toxicity | High HBT | 0.7449 |
Biodegradation | Ready biodegradable | 0.9131 |
Acute Oral Toxicity | III | 0.8351 |
Carcinogenicity (Three-class) | Non-required | 0.6470 |
From admetSAR
ADMET Predicted Profile --- Regression
Model | Value | Unit |
---|---|---|
Absorption | ||
Aqueous solubility | -3.9026 | LogS |
Caco-2 Permeability | 1.0388 | LogPapp, cm/s |
Distribution | ||
Metabolism | ||
Excretion | ||
Toxicity | ||
Rat Acute Toxicity | 1.6914 | LD50, mol/kg |
Fish Toxicity | 0.5798 | pLC50, mg/L |
Tetrahymena Pyriformis Toxicity | 1.7479 | pIGC50, ug/L |
From admetSAR